Bevantolol
From Self-sufficiency
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
200px | |
Systematic (IUPAC) name | |
---|---|
(RS)-[2-(3,4-dimethoxyphenyl)ethyl][2-hydroxy-3-(3-methylphenoxy)propyl]amine | |
Clinical data | |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | 59170-23-9 |
ATC code | C07AB06 (WHO) |
PubChem | CID 2372 |
DrugBank | DB01295 |
ChemSpider | 2282 |
Chemical data | |
Formula | C20H27NO4 |
Molar mass | 345.43 g/mol[[Script error: No such module "String".]] |
Script error: No such module "collapsible list". | |
(verify) |
Bevantolol (INN) is a drug which acts as both a beta blocker and a calcium channel blocker.
30px | This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. |
Retrieved from "http://ssf.f15ijp.com/wiki/index.php?title=Bevantolol&oldid=22391"
Categories:
- Pages with script errors
- Pages with broken file links
- Drugs with non-standard legal status
- Infobox drug articles with non-default infobox title
- Infobox drug tracked parameters
- Articles without EBI source
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Beta blockers
- Phenol ethers
- Alcohols
- Amines
- Cardiovascular system drug stubs
- 2Fix